A huge percentage of what psychiatrists prescribe is off-label, and most patients have no idea, which is its own problem.
Sections
A huge percentage of what psychiatrists prescribe is off-label, and most patients have no idea, which is its own problem. Off-label doesn’t mean unsafe or experimental. It means the medication is being used for something other than what’s on the official FDA-approved indication list. In psychiatry, that’s the rule, not the exception. Most of the prescriptions written in this field are not technically for what the FDA said the drug is for.
The reason is that psych medications often work for several different things, and the FDA approval process is slow and expensive, so drug companies don’t usually bother getting additional indications added once the original patent paid off. The clinical evidence accumulates faster than the regulatory paperwork. By the time something is widely accepted as a treatment for X, it might still officially be approved only for Y. That doesn’t mean the X use is wrong. It means the paperwork hasn’t caught up with the practice.
Examples of common off-label uses
Trazodone is FDA-approved as an antidepressant. Almost nobody uses it for that anymore. It’s used almost exclusively for sleep, off-label, at doses way lower than what they originally tested it for. This is so universal that most prescribers forget it’s even off-label. If your PCP prescribed you trazodone, they prescribed you an antidepressant being used off-label as a sleep medication, and they probably didn’t mention either of those things.
Seroquel (quetiapine, an atypical antipsychotic, the newer-generation class that doesn’t cause the movement disorders the older Haldol-style drugs did) is approved for schizophrenia, bipolar, and as an add-on for depression. It gets prescribed off-label for insomnia at low doses constantly, often by PCPs who think they’re prescribing a sleep medication, not an antipsychotic. The patient should know what they’re taking, because the side-effect profile of an antipsychotic isn’t the same as the side-effect profile of a sleep aid, even at low doses, and you might not be thrilled to find out what you’ve been on for two years.
Gabapentin (originally developed for seizures, now used for basically everything that ends in “iness”) is approved for seizures and certain nerve pain conditions. It gets prescribed off-label for anxiety, alcohol withdrawal, restless leg, sleep, and a whole list of other stuff. The evidence varies dramatically by indication. Some of these uses are well-supported. Others, less so. Patients usually don’t know which category their case falls into.
Wellbutrin (bupropion, the antidepressant that works on dopamine and norepinephrine instead of serotonin, the one that doesn’t tank your sex life like the SSRIs) is approved for depression and smoking cessation. It’s used off-label as an add-on for ADHD, particularly for people who can’t or won’t take stimulants, and to counteract the sexual side effects of SSRIs. Both of those uses have decent evidence behind them. Neither is technically on-label.
Beta blockers like propranolol are approved for blood pressure and certain heart rhythm issues. They get prescribed off-label for performance anxiety, situational social anxiety (the wedding-toast kind, not the every-day kind), and tremor. The evidence for the performance-anxiety use is solid. The “I’m scared of public speaking” pill predates SSRIs by decades and works mostly by blocking the physical symptoms of the panic response.
What evidence levels actually look like
The label status tells you nothing about how strong the evidence is for a particular use. Some off-label uses are supported by huge trials and decades of clinical experience. Some are supported by one small study and a hunch somebody had in 1997 that became the way it gets done.
Trazodone for sleep, the most common example, has a surprisingly thin evidence base for the way it gets used. Most clinicians prescribe it because it tends to work and the side-effect profile is favorable, not because there’s a stack of randomized controlled trials in the literature. That’s worth knowing. Doesn’t mean don’t take it. Means know what kind of evidence is behind it.
Lamictal (lamotrigine, a mood stabilizer that started as a seizure medication and migrated into psychiatry) for bipolar II depression was off-label initially and the evidence accumulated so heavily that it eventually became on-label. The treatment pattern preceded the official approval. That happens often, and it’s not a sign anything was being done wrong, it’s a sign the field saw something working before the paperwork caught up.
SSRIs for premature ejaculation are off-label, with a strong evidence base, just not enough commercial reason for any of the drug companies to chase the indication when the patents are all expired and the prescriptions are happening anyway. Doesn’t make it wrong. Just makes it a use that won’t ever be on a label.
Why this matters for you
If your prescriber is offering you a medication, you should know whether it’s on-label or off-label for what they’re treating you for. Both can be perfectly fine. The difference is what kind of conversation you should be having about it.
On-label means there’s an approved indication and the data is right there in the official labeling. Standard treatment. The trial data exists and the FDA looked at it.
Off-label with strong evidence means the use is widely accepted and supported by clinical research, just not formally approved. Usually fine, but worth knowing the difference. The trazodone-for-sleep prescription is an example of this category, kind of, even though the evidence for sleep specifically is thinner than it should be.
Off-label with thin evidence means somebody had a hunch, it sometimes works, and you’re closer to experimenting with your own brain chemistry. That’s not automatically wrong, especially if you’ve already tried the standard things and they didn’t work, but you should know that’s what’s happening. Don’t take a medication thinking it’s a standard treatment when it’s actually a third-tier hope.
What this looks like in real life
Say you’ve got a guy who came in for an ADHD evaluation, wanted stimulants. He’d been to two providers before, both of whom had handed him stimulants without doing a real assessment, which is its own can of worms. We did the full evaluation. He had clear ADHD, no question. He’d also been started on Seroquel for sleep five years prior by his primary care, after a stretch of insomnia, and nobody had ever revisited it.
He didn’t know Seroquel was an antipsychotic. He knew it as “the sleep pill.” When I told him what it was actually approved for, and what class it sat in, he was unhappy. Not because the medication had hurt him, it hadn’t, really, beyond some weight gain. He was unhappy because nobody had bothered to explain what they’d put him on. He felt like he hadn’t been asked.
We tapered him off Seroquel over a few weeks, switched him to trazodone for sleep (still off-label, but this time he knew it) and got him started on a stimulant for the ADHD. He slept fine. He lost the weight he’d put on. He still occasionally brings up that conversation, the one where nobody had told him for five years what was actually in the bottle. It bugs him, and it should bug him. Not because anybody was malicious, but because the conversation was lazy.
Off-label doesn’t tell you anything about the strength of evidence behind a use. Some off-label uses are supported by huge trials. Some are supported by one small study and a hunch.
What to ask
When you start a new medication, ask: is this on-label or off-label for what you’re treating me for. If off-label, what’s the evidence base actually look like, and which category of off-label is this. What are the official approved uses of this drug, so I can read about them on my own.
If your prescriber bristles at the question, find a different one. The answer should be easy and respectful, and it’s not a trick question. Off-label prescribing is legal, common, and usually appropriate. Patients having no idea what they’re actually on is not appropriate, and it’s not the patient’s fault, it’s the prescriber’s.
A side note on cost and access: some insurance companies require prior authorization for off-label uses, which can be a pain in the ass to deal with at the pharmacy every month. If you’re starting something off-label, ask the prescriber and the pharmacy upfront whether your insurance is going to flag it, because the answer “we’ll find out at the counter” is the answer that means a forty-minute phone call later.
The field-critique piece
There’s a related issue worth naming, which is that psychiatry as a field is both too cautious about some off-label uses and too cavalier about others. The off-label uses backed by huge trials and twenty years of data get treated like they’re sketchy (“oh, you sure you want to try that off-label, hmm”) while the off-label uses backed by one study from 2003 get handed out like candy if they happen to be in fashion that year. There’s no consistency, and patients can’t tell from the outside which kind of off-label use they’re being offered. The prescriber’s confidence level is not a reliable signal here. Some prescribers are confidently wrong, and some are hedging on things that are actually well-supported. The only fix is to ask the question and look at the answer yourself.
The patient autonomy piece
If you’ve been told what your medication is, what it’s approved for, what the off-label evidence looks like, and you want to take it anyway, that’s your call. The job isn’t to gatekeep, it’s to make sure you actually know what you’re swallowing. Knowing it’s off-label doesn’t mean don’t take it. It means take it with information, the way you’d take any other medication you’d actually want to take seriously.
The flip side is also true. If you’ve been on something for years without ever being told it was off-label, and you decide once you find out that you’d rather try something on-label first, that’s also your call. Either direction is defensible. The undefensible part is being kept in the dark while the prescription gets refilled.
Bottom line
Off-label prescribing is a normal part of psychiatry and most of it is reasonable. The job as a patient is to know which category your medication falls into, because the conversation about whether to take it, how long to be on it, and what to monitor looks different depending on the strength of the evidence behind the use. Ask. Most prescribers are happy to answer if you ask in a normal way. The ones who aren’t are telling you something useful about what kind of prescriber they are. Listen to that.
